Exane Derivatives’s Abercrombie & Fitch ANF Stock Holding History

Exane Derivatives’s Portfolio ANF Stock Details ANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,000	Closed	-$147K	–	516
2015 Q3	$147K	Buy	+3,000	New	+$61K	0.02%	203

Other funds holding ANF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIM

Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

Exane Derivatives's ANF Position: Q3 2019 in Review

Exane Derivatives sold out of Abercrombie & Fitch (ANF) in Q3 2019, closing a stake of 5 shares — an estimated $80 sold.

Exane Derivatives first reported a position in ANF in Q4 2014 and held it in 15 quarters. The position peaked at $3.95M in Q3 2017. 198 funds tracked by Wall St. Rank hold ANF as of Q3 2019.

Exane Derivatives reported no remaining Abercrombie & Fitch position as of Q3 2019 after selling out during the quarter.
Exane Derivatives sold 5 Abercrombie & Fitch shares in Q3 2019, an estimated $80.
Exane Derivatives first reported a position in Abercrombie & Fitch in Q4 2014 and held it in 15 quarters.
Exane Derivatives's Abercrombie & Fitch position peaked at $3.95M in Q3 2017.
198 funds tracked by Wall St. Rank held Abercrombie & Fitch as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.